Tornado damage to a Pfizer drug-making plant in North Carolina is unlikely to trigger drug shortages across the country, the U.S. Food and Drug Administration says.
“We do not expect there to be any immediate significant impacts on supply, given the products are currently at hospitals and in the distribution system,” FDA Commissioner Robert Califf said in an agency news release posted Friday.
